The study will test a medicine called anifrolumab to see if it helps adults with lupus nephritis, a kidney disease caused by lupus. Lupus is when your immune system, which usually fights germs, attacks your body instead. This study is Phase 3, meaning it’s in late stages of testing. Participants will be randomly chosen to receive either the medicine or a placebo, which is a fake treatment. Everyone will continue their usual care with other medicines like MMF (mycophenolate mofetil) and glucocorticoids (a type of steroid). The study lasts about 116 weeks, which is more than two years, and involves 360 people. You need a recent kidney test to join, and there are some health conditions that might stop you from participating.
- Study duration is about 116 weeks, including screening and follow-up.
- Participants will be randomly assigned to receive the study drug or a placebo.
- Ongoing standard treatment with MMF and glucocorticoids will continue.
How understandable was the trial content above?
Hard to understand
Easy to understand